Hypothesis
The age‑related rise in mismatch‑repair deficiency and field carcinogenesis in the colon is not merely accumulated damage but the output of a conserved inflammatory program that was selected to limit stem‑cell clonal expansion early in life. This program, now active post‑reproductively, enforces a homeostatic ceiling on mutant clone size; interfering with it should reduce late‑life cancer risk without compromising early‑life tissue renewal.
Background
Epidemiological data show colorectal cancer incidence doubling each decade after 40 and a sharp increase in dMMR tumors in individuals over 80, especially women [1, 2]. Experimental work demonstrates that inflammatory cytokines are required for the expansion of mutated clones in field carcinogenesis [3] and that DNMT3A/TET2‑mutant clonal hematopoiesis expands via similar pro‑inflammatory signaling [4]. These observations fit antagonistic pleiotropy: pathways that boost early‑life fitness (e.g., rapid epithelial repair) become deleterious later.
Mechanistic Insight
We propose that a specific cytokine axis—IL‑6 trans‑signaling via soluble IL‑6R—acts as an evolutionary “brake” on stem‑cell progeny. In youth, transient IL‑6 bursts promote barrier regeneration after injury while simultaneously activating STAT3‑dependent expression of differ





























